A randomized, double-blind, placebo-controlled phase 2 study of intratympanic OTO-313 in patients with moderate to severe subjective tinnitus

PURPOSE: This was a randomized, double-blind, placebo-controlled Phase 2 study to evaluate the efficacy and safety of intratympanic OTO-313 in patients with subjective unilateral tinnitus. METHODS: Patients with moderate to severe unilateral tinnitus of 2–12 months duration were enrolled. A single i...

Descripción completa

Detalles Bibliográficos
Autores principales: Searchfield, Grant D., Robinson, James M., Skarinsky, David, Wang, Yiwei, Anderson, Jeffery J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Otology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620247/
https://www.ncbi.nlm.nih.gov/pubmed/37341760
http://dx.doi.org/10.1007/s00405-023-08047-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620247/
https://www.ncbi.nlm.nih.gov/pubmed/37341760
http://dx.doi.org/10.1007/s00405-023-08047-0

Ejemplares similares